Cargando…

Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries

BACKGROUND: Chronic Thromboembolic Pulmonary Hypertension (CTEPH) results from incomplete resolution of a pulmonary embolus, leading to pulmonary hypertension and progressive right heart failure and death. We aimed to describe the demographics, treatment patterns, health resource utilization and rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schweikert, Bernd, Pittrow, David, Vizza, Carmine Dario, Pepke-Zaba, Joanna, Hoeper, Marius M, Gabriel, Anja, Berg, Jenny, Sikirica, Mirko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069093/ https://www.ncbi.nlm.nih.gov/pubmed/24912804 http://dx.doi.org/10.1186/1472-6963-14-246

Ejemplares similares

Medical management of chronic thromboembolic pulmonary hypertension
por: Pepke-Zaba, Joanna, et al.
Publicado: (2017)

Chronic thromboembolic pulmonary hypertension: time for research in pathophysiology to catch up with developments in treatment
por: Toshner*, Mark, et al.
Publicado: (2014)

Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension
por: Hoeper, Marius M.
Publicado: (2015)

Quality of life in patients with chronic thromboembolic pulmonary hypertension
por: Mathai, Stephen C., et al.
Publicado: (2016)

Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany
por: Kramm, Thorsten, et al.
Publicado: (2018)

Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables
por: Pausch, Christine, et al.
Publicado: (2023)

Author's reply
por: Pepke-Zaba, Joanna
Publicado: (2012)

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension
por: Toshner, Mark R., et al.
Publicado: (2010)

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study
por: McLaughlin, Vallerie V., et al.
Publicado: (2017)

Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021
por: Simonneau, Gérald, et al.
Publicado: (2023)

Investigating significant health trends in idiopathic pulmonary fibrosis (INSIGHTS-IPF): rationale, aims and design of a nationwide prospective registry
por: Behr, Juergen, et al.
Publicado: (2014)

Endothelin ET(A) receptors predominate in chronic thromboembolic pulmonary hypertension
por: Southwood, Mark, et al.
Publicado: (2016)

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
por: Belge, Catharina, et al.
Publicado: (2020)

Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience
por: Hoole, Stephen P, et al.
Publicado: (2020)

Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension
por: Swietlik, Emilia M., et al.
Publicado: (2021)

An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan
por: Gall, Henning, et al.
Publicado: (2017)

Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
por: Bhamani, Amyn, et al.
Publicado: (2019)

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Humbert, Marc, et al.
Publicado: (2019)

The European LEMS Registry: Baseline Demographics and Treatment Approaches
por: Mantegazza, Renato, et al.
Publicado: (2015)

Open Data Resources on COVID-19 in Six European Countries: Issues and Opportunities
por: Pecoraro, Fabrizio, et al.
Publicado: (2021)

Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)
por: Ghofrani, Hossein A, et al.
Publicado: (2009)

Comment on Topyła-Putowska et al. Echocardiography in Pulmonary Arterial Hypertension: Comprehensive Evaluation and Technical Considerations. J. Clin. Med. 2021, 10, 3229
por: Manzi, Giovanna, et al.
Publicado: (2022)

Obesity-related complications, healthcare resource use and weight loss strategies in six European countries: the RESOURCE survey
por: Evans, Marc, et al.
Publicado: (2023)

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias
por: Hoeper, Marius M., et al.
Publicado: (2015)

CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Medication and patient factors associated with adherence to pulmonary hypertension targeted therapies
por: Grady, Duncan, et al.
Publicado: (2017)

Ventriculo‐arterial coupling detects occult RV dysfunction in chronic thromboembolic pulmonary vascular disease
por: Axell, Richard G., et al.
Publicado: (2017)

Demographics of the European Apicultural Industry
por: Chauzat, Marie-Pierre, et al.
Publicado: (2013)

Demographic Strengthening of European Identity
por: Striessnig, Erich, et al.
Publicado: (2016)

Venous thromboembolism 2011–2018 in Stockholm: a demographic study
por: Wändell, Per, et al.
Publicado: (2019)

The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease
por: Hadinnapola, Charaka, et al.
Publicado: (2015)

Trends in marriage and time spent single in sub-Saharan Africa: a comparative analysis of six population-based cohort studies and nine Demographic and Health Surveys
por: Marston, M, et al.
Publicado: (2009)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Benza, Raymond L., et al.
Publicado: (2022)

The demographic, clinical, and medical manifestations of pulmonary thromboembolism development in COVID-19
por: Sadeghi, Somayeh, et al.
Publicado: (2021)

Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial
por: Vizza, Carmine Dario, et al.
Publicado: (2017)

The Gen-Equip Project: evaluation and impact of genetics e-learning resources for primary care in six European languages
por: Jackson, Leigh, et al.
Publicado: (2018)

The European demographic system 1500–1820
por: Wrigley, E. A.
Publicado: (1982)

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
por: Kim, Nick H, et al.
Publicado: (2017)

The Implications of Demographic Changes on Resource Allocation
por: Andrews, Keith, et al.
Publicado: (1985)

Saliva Cortisol and Exposure to Aircraft Noise in Six European Countries
por: Selander, Jenny, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_5kf1o2gh8n3hhh4ma0qhn1tfeq